Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.

2546 Background: We recently reported that tumor cell vaccines cultured in 5% oxygen (O2) had enhanced the immunogenicity relative to those grown in standard atmospheric O2. In order to develop an ...